Financials

  • Market Capitalization 3.29 B
  • Employee 370
  • Founded 2016
  • CEO N/A
  • Website www.tarsusrx.com
  • Headquarter Delaware, United States
  • FIGI BBG00RB9BNQ7
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-51.5
Relación precio/flujo de caja
7.58

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
1582
ARQT
Arcutis Biotherapeutics, Inc. - Common stock
26.30 USD-1.05%+5.75%+9.36%+30.00%3.31 B USD
1588
VKTX
Viking Therapeutics, Inc. - Common Stock
28.61 USD+0.35%-1.89%-9.75%-15.88%3.34 B USD
1595
CELC
Celcuity Inc. - Common Stock
66.75 USD-1.75%-5.87%-19.92%+42.48%3.27 B USD
1622
AMLX
Amylyx Pharmaceuticals, Inc. - Common Stock
27.80 USD-1.21%+0.65%-12.69%+95.22%3.10 B USD

Noticias